Suven Life Sciences shares up 5% on patents from Europe, Israel

Suven Life Sciences shares rallied more than 5 percent intraday Tuesday after getting patents from Europe and Israel.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney master your money IThe Winning Leap SME Special
Moneycontrol

Home » News » Buzzing Stocks

Oct 18, 2016, 10.40 AM | Source: Moneycontrol.com

Suven Life Sciences shares up 5% on patents from Europe, Israel

Suven Life Sciences shares rallied more than 5 percent intraday Tuesday after getting patents from Europe and Israel.

Like this story, share it with millions of investors on M3

Suven Life Sciences shares up 5% on patents from Europe, Israel

Suven Life Sciences shares rallied more than 5 percent intraday Tuesday after getting patents from Europe and Israel.

Post Your Comments

Share Cancel

Moneycontrol Bureau

Suven Life Sciences shares rallied more than 5 percent intraday Tuesday after getting patents from Europe and Israel.

"...announces that the grant of one product patent from Europe and one product patent from Israel corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases," the healthcare company said in its filing.

These patents are valid through 2030 and 2029 respectively. These are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like alzheimer's disease, attention deficient hyperactivity disorder (ADHD), huntington’s disease, major depressive disorder, parkinson and schizophrenia.

With these new patents, Suven has a total of 23 granted patents from Europe and 12 granted patents from Israel.

"These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II," the company said.

At 10:27 hours IST, the scrip of Suven Life Sciences was quoting at Rs 199.20, up Rs 5.05, or 2.60 percent on the BSE.

Posted by Sunil Shankar Matkar

Buy, Hold, Sell ? Hear it first on M3
Suven Life Sciences shares up 5% on patents from Europe, Israel

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login